EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
(Part 4)
Allow me to continue with the discussion on the formulation of difficult to treat (D2T) rheumatoid arthritis (RA).
As we have discussed in the past few weeks, the European Alliance of Associations of Rheumatolpgy (EULAR) decided to come up to formulate points to consider (PtC) to guide the clinicians and healthcare professionals (HCP) on the management of D2T RA.
As an initial step, a definition and a uniform term for the D2T RA patient population had to be established.
The Steering Committee proposed the terminology and created a first draft of a definition.
Guided by the results of the international survey and a scoping literature review, the definitions were discussed with the whole EULAR Task Force and amended during the first Task Force meeting , which was held in August 2018.
The final terminology and definition were agreed through a voting process.
All Task Force members agreed with ‘D2T RA’ as the term and the final definition.
Next week we will go deeper in the discussion by giving the details on the terminology and the definition of D2T RA.